Sirius XM Holdings Inc. (SIRI) Raises PT to $22 by Morgan Stanley, Finalizes Multi-Year Agreement with Morbid
ByAinvest
Friday, Aug 1, 2025 10:41 am ET1min read
MS--
The deal comes as Sirius XM continues to navigate a challenging market environment. The company reported a 2% decline in revenue in the second quarter of 2025, with GAAP earnings per share falling short of analyst expectations by $0.20 [1]. Despite these financial pressures, Sirius XM's free cash flow increased by 27% year-over-year, supported by cost reductions [1].
Morgan Stanley has recently raised its price target on SIRI from $21 to $22, but maintains an "Underweight" rating, citing persistent secular pressures and the unchanged path to deleveraging [2]. The investment bank's analyst, however, acknowledges the potential upside from the new content partnerships.
In addition to the "Morbid" deal, Sirius XM has also declared a quarterly dividend of $0.27 per share, continuing its commitment to shareholder returns [1]. The company's focus on cost management and operational efficiency, along with its strategic content investments, will be key factors to watch as it seeks to maintain and grow its subscriber base.
References:
[1] https://www.nasdaq.com/articles/sirius-xm-siri-q2-revenue-rises-2
[2] https://www.marketbeat.com/instant-alerts/filing-seizert-capital-partners-llc-grows-stock-holdings-in-sirius-xm-holdings-inc-nasdaqsiri-2025-07-30/
SIRI--
Sirius XM Holdings Inc. (SIRI) has finalized a multi-year agreement with popular true crime podcast "Morbid". The deal grants SIRI exclusive distribution and ad sales rights for the podcast's video and audio versions. Morgan Stanley has raised its price target on SIRI from $21 to $22, but maintains an "Underweight" rating, citing persistent secular pressures and the unchanged path to deleveraging. SIRI has also declared a quarterly dividend of $0.27 per share.
Sirius XM Holdings Inc. (SIRI) has announced a multi-year agreement with the popular true crime podcast "Morbid," granting the company exclusive distribution and ad sales rights for the podcast's video and audio versions. This strategic partnership aims to diversify Sirius XM's content offerings and capitalize on the growing popularity of true crime podcasts.The deal comes as Sirius XM continues to navigate a challenging market environment. The company reported a 2% decline in revenue in the second quarter of 2025, with GAAP earnings per share falling short of analyst expectations by $0.20 [1]. Despite these financial pressures, Sirius XM's free cash flow increased by 27% year-over-year, supported by cost reductions [1].
Morgan Stanley has recently raised its price target on SIRI from $21 to $22, but maintains an "Underweight" rating, citing persistent secular pressures and the unchanged path to deleveraging [2]. The investment bank's analyst, however, acknowledges the potential upside from the new content partnerships.
In addition to the "Morbid" deal, Sirius XM has also declared a quarterly dividend of $0.27 per share, continuing its commitment to shareholder returns [1]. The company's focus on cost management and operational efficiency, along with its strategic content investments, will be key factors to watch as it seeks to maintain and grow its subscriber base.
References:
[1] https://www.nasdaq.com/articles/sirius-xm-siri-q2-revenue-rises-2
[2] https://www.marketbeat.com/instant-alerts/filing-seizert-capital-partners-llc-grows-stock-holdings-in-sirius-xm-holdings-inc-nasdaqsiri-2025-07-30/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet